Ablitech's bio-transformable, drug-eluting material creates innovative opportunities in biomedical materials market. Through precise control of the polymer/drug structure and architecture, this approach to material design provides a rigid material for support during the initial stages of healing which then bio-transforms to more closely match the physical properties and permeability of natural tissues. Firm appears to have ceased operations as of 2013
